[go: up one dir, main page]

AR026705A1 - Forma triturada - Google Patents

Forma triturada

Info

Publication number
AR026705A1
AR026705A1 ARP000106385A ARP000106385A AR026705A1 AR 026705 A1 AR026705 A1 AR 026705A1 AR P000106385 A ARP000106385 A AR P000106385A AR P000106385 A ARP000106385 A AR P000106385A AR 026705 A1 AR026705 A1 AR 026705A1
Authority
AR
Argentina
Prior art keywords
refers
compound
pharmaceutically acceptable
reduced particle
particle size
Prior art date
Application number
ARP000106385A
Other languages
English (en)
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of AR026705A1 publication Critical patent/AR026705A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/26—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring
    • C07C271/28—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring to a carbon atom of a non-condensed six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La presente se refiere a un tamano de partícula reducido del compuesto ácido 3-{4-[2-(4-terc-butoxicarbonilaminofenil)etoxi]fenil}-(S)-2-etoxi propanoico,segun formula (1) o su sal farmacéuticamente aceptable o un solvato de cualquiera de ellos. La p resente también se refiere a los métodos para tratar una o máscondiciones asociadas con el Síndrome de Resistencia a la Insulina usando la forma de tamano de partícula reducido del compuesto, o su sal farmacéuticamenteaceptable para la fabricacion de un medicamento para usar para una o más de dichas condiciones. La presente también se refiere a las composicionesfarmacéuticas que contienen la forma de tamano de partícula reducido del compuesto, o su sal farmacéuticamente aceptable, o su solvato, como ingrediente activo, así como también se refiere a los procesos para la fabricacion de la forma de tamano de partícula reducido del compuesto o su sal farmacéuticamente aceptable.
ARP000106385A 1999-12-03 2000-12-01 Forma triturada AR026705A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9904412A SE9904412D0 (sv) 1999-12-03 1999-12-03 Comminuted form

Publications (1)

Publication Number Publication Date
AR026705A1 true AR026705A1 (es) 2003-02-26

Family

ID=20417977

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000106385A AR026705A1 (es) 1999-12-03 2000-12-01 Forma triturada

Country Status (5)

Country Link
AR (1) AR026705A1 (es)
AU (1) AU2034701A (es)
CO (1) CO5271723A1 (es)
SE (1) SE9904412D0 (es)
WO (1) WO2001040166A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6369067B1 (en) 1997-10-27 2002-04-09 Dr. Reddy's Research Foundation Monocyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them
US6440961B1 (en) 1997-10-27 2002-08-27 Dr. Reddy's Research Foundation Tricyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them
CN100376560C (zh) 1997-10-27 2008-03-26 雷迪实验室有限公司 新型三环化合物和其作为药物的用途;其制备方法和包含该化合物的药物组合物
CN1280574A (zh) 1997-10-27 2001-01-17 雷迪研究基金会 新的杂环化合物及其在医药中的应用、它们的制备方法和含有它们的药物组合物
RU2247722C2 (ru) 1997-10-27 2005-03-10 Др. Редди`З Лабораториз Лимитед Производные арилкарбоновых кислот, способы их получения, фармацевтическая композиция на их основе, способы лечения и предупреждения различных заболеваний, промежуточные соединения и способы их получения
US6531596B1 (en) 1998-10-29 2003-03-11 Dr. Reddy's Laboratories Ltd. Process for the preparation of new antidiabetic agents
PL347208A1 (en) 1998-10-29 2002-03-25 Reddy S Res Fundation Dr An improved process for the preparation of new antidiabetic agents
US6897199B2 (en) 2001-02-05 2005-05-24 Dr. Reddy's Laboratories Ltd. Pharmaceutically acceptable salts of phenoxazine and phenothiazine compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA26634A1 (fr) * 1998-06-04 2004-12-20 Astra Ab Nouveaux derives de l'acide 3-aryl propionique et analogues
SE9801990D0 (sv) * 1998-06-04 1998-06-04 Astra Ab New 3-aryl propionic acid derivatives and analogs

Also Published As

Publication number Publication date
AU2034701A (en) 2001-06-12
CO5271723A1 (es) 2003-04-30
SE9904412D0 (sv) 1999-12-03
WO2001040166A1 (en) 2001-06-07

Similar Documents

Publication Publication Date Title
AR029456A1 (es) Forma triturada
EA201000643A1 (ru) Замещенное производное этилендиамина для лечения микобактериальных заболеваний и фармацевтическая композиция на его основе
NO20076613L (no) Farmasoytiske formuleringer og anvendelse derav
AR039335A1 (es) Tableta de carga de droga alta
CO6160236A2 (es) Inhibidor de quinasa
WO2007082808A3 (en) Thiazoles as 11 beta-hsd1 inhibitors
GT200000216A (es) Oxazolidinonas sustituidas y su uso.
AR067495A1 (es) Composiciones farmaceuticas y procedimientode tratamientos de trastornos de ojo seco
ECSP066950A (es) Combinaciones de glicopirrolato y agonistas del adrenoceptor-beta2
AR048431A1 (es) Formulaciones galenicas de compuestos organicos
GT200100183A (es) Derivados de quinolina y quinazolina.
SG166791A1 (en) Novel macrocyclic inhibitors of hepatitis c virus replication
AR053162A1 (es) Compuesto 5 - oxo - pirrolidin sustituido, composicion farmaceutica que lo comprende y su uso para preparar un medicamento para el tratamiento del glaucoma.
PT1119543E (pt) N-aralquilaminotetralinas como ligandos para o receptor y5 do neuropeptido y
SE0301882D0 (sv) New use I
HN2004000232A (es) " derivados de pirrolo(3,4-c) pirazol activos como inhibidores de quinasa, proceso para su preparacion y composiciones farmaceuticas que los comprenden."
AR033688A1 (es) Composicion parenteral reconstituible
ECSP055528A (es) Composicion farmaceutica que tiene una distribución y potencia uniforme de farmaco
AR029412A1 (es) Forma cristalina
TW200643013A (en) Pyrazoles
AR056575A1 (es) Compuesto de (alfa)-aminocarboxiamida que es 5-(4-[[(2-fluorofenil) metil] oxi] fenil)prolinamida, composicion farmaceutica que lo comprende, su uso para la fabricacion de un medicamento y proceso para prepararlo
GT200600163A (es) Nuevas combinaciones terapeuticas para el tratamiento o la prevencion de la depresion
UY27018A1 (es) Derivados de la pirimidina
UY29085A1 (es) Derivados de pirimidina 4-sulfonamido sustituidos, compuestos intermedios para su preparación, procedimientos de preparación, composiciones medicinales conteniéndolos y aplicaci0nes
AR062393A1 (es) Uso de derivado del 2.5-dihidrixibenceno para el tratamiento de artritis y dolor

Legal Events

Date Code Title Description
FB Suspension of granting procedure